AgraFlora Organics International Inc is a cannabis company building shareholder value through the development of revenue-generating, operated assets in the global cannabis industry. It is focused primarily on the Canadian cannabis industry. Its flagship Canadian asset is Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low-cost cannabis. In addition, the company through its subsidiary is focused on becoming Europe's distributor of medical cannabis.

AGRAFLORA ORGANICS INTL by Agraflora Organics Intl Inc.

AgraFlora Organics Intl

Scotiabank analyst Ben Isaacson upgrades Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Sector Underperform to Sector Perform and announces $104 price target.

News

Upgrades

Price Target

Analyst Ratings

Scotiabank Upgrades Westlake Chemical to Sector Perform, Announces $104 Price Target

More than 1,050&nbsp;Letters Filed Supporting CP-KCS Combination or in Opposition to the CN Proposal&nbsp;
Customers Losing Service Options Voice Concerns
&nbsp;
CALGARY, AB, June 21, 2021 /PRNewswire/ -&nbsp;Canadian Pacific Railway Limited (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CP#TSX">CP</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) (&quot;CP&quot;) today announced that more than 80 additional stakeholders have filed statements with the Surface Transportation Board (&quot;STB&quot;) expressing concerns about Canadian National (&quot;CN&quot;) and Kansas City Southern&#39;s (&quot;KCS&quot;) combination, its use of a voting trust, or both. This brings the total opposed to over 330.&nbsp;Together, more than 1,050 letters have been&nbsp;filed in support of CP&#39;s proposed combination with KCS or in opposition to the CN proposal.
Shippers that could lose shipping options in the New Orleans to Baton Rouge corridor have also submitted letters in opposition to CN&#39;s voting trust, including Pinnacle Polymers, which notes: &quot;&hellip;we are closely monitoring this issue and ardently believe that the use of a trust for any merger under the 2001 Major Merger Rules would not be in our interest, much less the public interest.&quot;
Last week, SMART-Transportation Division, North America&#39;s largest railroad operating union, submitted <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3202308-1&amp;h=1942363177&amp;u=https%3A%2F%2Fwww.cpr.ca%2Fen%2Fmedia%2Fnorth-america%25E2%2580%2599s-largest-railroad-operating-union-joins-others-and-calls-on-stb-to-reject-cn-voting-trust&amp;a=a+letter" target="_blank">a letter</a> urging the STB to reject CN&#39;s proposed use of a voting trust.
The letters highlight the extensive risks the proposed CN-KCS voting trust poses to competition by reducing shipper options. Stakeholders also expressed strong concerns over the likelihood of reduced service quality and infrastructure investments as a result of the proposed CN transaction.
Public Comment Period for CN Voting Trust
In line with the public comment period, CP plans to file comments no later than June 28, explaining why the public interest costs of CN&#39;s proposed voting trust outweigh the non-existent benefits. This public comment period, and the STB&#39;s subsequent deliberations, will determine the course of competition for U.S. railroading and North American commerce for the next 150 years.
Now is the time for stakeholders to voice their concerns about whether CN should be able to lock in its anti-competitive plan to buy KCS via a voting trust. Stakeholders can express their concerns directly to the STB.&nbsp;
Importantly, the STB has already approved CP&#39;s use of a voting trust and affirmed KCS&#39; waiver from the new rail merger rules it adopted in 2001 because a CP-KCS combination is truly end-to-end, pro-competitive, and the only viable Class 1 combination.
As previously announced, CP is continuing to pursue its application process to acquire KCS so that the pro-competitive CP-KCS combination can be reviewed by the STB and implemented without undue delay, in the event KCS&#39; agreement with CN is terminated or CN is otherwise unable to acquire control of KCS.
For more information on the benefits of a CP-KCS combination and the risks that a CN-KCS transaction would pose to the railway industry and North America, visit FutureForFreight.com.

TSX:CP

Canadian Pacific Railway Reports 80+ Added Stakeholders Filed Statements With Surface Transportation Board Expressing Concerns About Co. Deal With Kansas City Southern

SOS Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOS#NYSE">SOS</a>) (the &quot;Company&quot;or &quot;SOS&quot;) announced today that it has entered into a joint venture agreement with Niagara Development LLC (&quot;Niagara Development&quot;), a New Jersey limited liability company, for a joint venture to be based in Niagara, Wisconsin.&nbsp;
The joint venture, FD LLC, is expected to carry out crypto-currency mining operations and construct&nbsp;an international standardized Digital Super Computing Custody Operation Center.
Under terms of the agreement, Niagara Development will be responsible for providing up to 150MW of electricity, including electricity generated from renewable sources, and construction the Digital Super Computing Custody Operation Center. SOS will be responsible for the management, operations and financing of the joint venture. SOS remains committed to its block-chain strategy and strive to become a sustainability leader in the industry.
In response to developments in the laws and regulations pertaining to blockchain operations in China, SOS has begun shifting its bitcoin mining operations to the U.S. The majority of SOS&#39; China operations, namely, its insurance businesses, call centers and ethereum mining businesses, remain unaffected and fully operational.
Yandai Wang, Chairman of SOS, commented, &quot;SOS continues to increase its development of comprehensive blockchain solutions for digital trade, digital finance and other industries. We decided to acquire a sustainable power supply&nbsp;as far as possible, as we expand our blockchain operations into North America and look forward to successful operation of the joint venture. We continue to explore the possibility of acquisition of Niagara Development, Sherman Development LLC, and Park Falls Management LLC. Although at this point, we do not have any definitive agreement for such acquisition, we remain optimistic about our strategic expansion in North America.&quot;
SOS is an emerging marketing and solution provider based on blockchain and big data. It has about 20 million members in China. In July 2020, the headquarters of SOS moved from Gui&#39;an new area to Qingdao West Coast new area. SOS has outlined its strategy in blockchain and cryptocurrency, including a series of measures to expand its business to cryptocurrency mining and cryptocurrency security and insurance. The core infrastructure of SOS&#39; marketing data, technology and solutions to insurance and emergency rescue services is built on big data, blockchain-based technology, cloud computing, AI, satellite, and 5G network, etc. SOS has created a cloud &quot;software as a service (SaaS)&quot; platform for emergency rescue services, with three major product categories: basic cloud, cooperative cloud, and information cloud. This system provides innovative marketing solutions to clients, such as insurance companies, financial institutions, medical institutions, healthcare providers, auto manufacturers, and other service providers in the emergency rescue services industry.
SOS has obtained a national high-tech enterprise certification and the title of &quot;Big Data Star Enterprise,&quot; awarded by the Gui&#39;an New District Government. Staying on the forefront of digital technology innovation, the Company has registered 99 software copyrights and 3 patents. For more information, please visit: <a href="http://www.sosyun.com/" target="_blank">http://www.sosyun.com/</a>&nbsp;&nbsp;

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Contracts

Markets

SOS Reports Joint Venture With Niagara Development, Accelerates Blockchain Operations Into US

<h1>Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-&kappa;B in Murine Model of Adult T-Cell Leukemia / Lymphoma</h1>
<ul>
<li>Treatment with OligoPhoreTM&nbsp;siRNA stops aggressive ATLL tumor growth to near zero</li>
<li>Significant reduction in tumor size, spleen size and peripheral blood lymphocyte counts</li>
<li>Results add to extensive body of evidence for effective OligoPhoreTM&nbsp;enabled delivery of nucleic acids to extrahepatic tissues

	&nbsp;</li>
</ul>
Hamilton, Bermuda, June 21, 2021 &ndash; Auris Medical Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EARS#NASDAQ">EARS</a>), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the publication of positive results from an&nbsp;in vivo&nbsp;study demonstrating significant inhibition of tumor growth by siRNA knock-down of NF-&kappa;B employing its OligoPhoreTM&nbsp;technology in Adult T-cell Leukemia Lymphoma (ATLL). The article titled &quot;Targeting NF-&kappa;B with nanotherapy in a mouse model of adult T-cell leukemia / lymphoma&quot; was published in&nbsp;Nanomaterials, an international peer-reviewed open-access journal.1
The study was performed jointly by research groups at Washington University, St. Louis MO, and the University of South Florida, Tampa FL. The researchers developed and evaluated RNA nanoparticles based on Auris Medical&#39;s OligoPhoreTM&nbsp;peptide carrier and siRNA targeting simultaneously two NF-&kappa;B signaling pathways. NF-&kappa;B is a protein complex that plays a key role in regulating the immune response to infection and is critical for tumor progression in ATLL. The siRNA nanoparticles were administered systemically to two groups of mice with either spontaneous ATLL tumor growth or tumor cell transplantation.
The study demonstrated rapid delivery of siRNA to the tumor and significant reduction of target mRNA and protein expression, which altered the natural history of subsequent tumor progression. Tumor size, spleen size, and peripheral blood lymphocyte counts were significantly lower in treated mice compared to controls (p&lt;0.01), and tumor growth was reduced to near zero in the most aggressive tumors. Further, the siRNA nanoparticles sensitized late-stage ATLL tumors to conventional chemotherapy with etoposide.
ATLL is a rare and aggressive type of non-Hodgkin&#39;s lymphoma of mature T cells caused by the Human T-cell Leukemia / Lymphotropic Virus type 1 (HTLV 1). It can be found in the blood, lymph nodes, skin or other parts of the body. There are 5-10 million people infected with HTLV 1 globally, and it is estimated that 61 out of 100,000 of carriers will develop ATLL annually. The virus is endemic to Japan, sub Saharan Africa, South America, the Caribbean, central Australia, the Middle East, and Romania. Most cases are not curable with current treatments, even when diagnosed early. The 5-year survival rate is&nbsp;23.4%&nbsp;with a median survival of 11 months. Overall survival has remained unchanged since the disease was first described.
&quot;We are very excited about the very encouraging results from the study in ATLL mice&quot;, commented Samuel Wickline, MD, Auris Medical&#39;s Chief Scientific Officer. &quot;ATLL is a very challenging condition with high mortality rate. Although NF-&kappa;B has been known for some time as a promising target, it has remained elusive to specific and effective treatment so far. With the use of OligoPhore technology, siRNA targeting NF-&kappa;B can be delivered intravenously and track the tumor very effectively with profound suppression of aggressive tumor proliferation. Since ATLL is a highly malignant tumor with no targeted molecular therapy at present, this outcome is not only very encouraging for drug discovery and development in this therapeutic indication, but also for other tumors and inflammatory pathological conditions involving the NF-&kappa;B molecular target.&quot;
About&nbsp;OligoPhoreTM
OligoPhoreTM&nbsp;is a versatile platform for safe and effective delivery of oligonucleotides such as siRNA (small interfering ribonucleic acid) into target cells. It is based on a proprietary 21 amino acid peptide that can engage any type of RNA in rapid self-assembly into a polyplex. The polyplex has a size, charge, and other physical features that allow it to escape hepatic clearance and thus to reach other target tissues than the liver. OligoPhoreTM&nbsp;protects the RNA payload from degradation in the circulation and allows for rapid cellular uptake, while enabling pH-dependent nucleotide endosomal escape and cytoplasmic delivery. Effective delivery and positive treatment outcomes have been demonstrated in more than 10 murine models of disease for targets in the NF-&kappa;B family, various members of the ETS transcription factor family, and targets in the JNK and TAM pathways.
About Auris Medical
Auris Medical is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in three areas: the development of RNA therapeutics for extrahepatic therapeutic targets (OligoPhoreTM&nbsp;/ SemaPhoreTM&nbsp;platforms; preclinical), nasal sprays for protection against airborne viruses and allergens (BentrioTM; pre-commercial) or the treatment of vertigo (AM-125; Phase 2), and the development of therapeutics for intratympanic treatment of tinnitus or hearing loss (Keyzilen&reg; and Sonsuvi&reg;, Phase 3). The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Auris Medical Holding Ltd. trade on the NASDAQ Capital Market under the symbol &quot;EARS.&quot; The Company will change its name to &quot;Altamira Therapeutics Ltd.&quot; and its ticker symbol to &quot;CYTO&quot;, subject to approval by a Special General Meeting of shareholders to be held on July 21, 2021.
Forward-looking Statements
This press release may contain statements that constitute &quot;forward-looking statements&quot; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financial or business performance or Auris Medical&#39;s strategies or expectations. In some cases, you can identify these statements by forward-looking words such as &quot;may&quot;, &quot;might&quot;, &quot;will&quot;, &quot;should&quot;, &quot;expects&quot;, &quot;plans&quot;, &quot;anticipates&quot;, &quot;believes&quot;, &quot;estimates&quot;, &quot;predicts&quot;, &quot;projects&quot;, &quot;potential&quot;, &quot;outlook&quot; or &quot;continue&quot;, or the negative of these terms or other comparable terminology. Forward-looking statements are based on management&#39;s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, but are not limited to, the approval and timing of commercialization of AM-301, Auris Medical&#39;s need for and ability to raise substantial additional funding to continue the development of its product candidates, the timing and conduct of clinical trials of Auris Medical&#39;s product candidates, the clinical utility of Auris Medical&#39;s product candidates, the timing or likelihood of regulatory filings and approvals, Auris Medical&#39;s intellectual property position and Auris Medical&#39;s financial position, including the impact of any future acquisitions, dispositions, partnerships, license transactions or changes to Auris Medical&#39;s capital structure, including future securities offerings. These risks and uncertainties also include, but are not limited to, those described under the caption &quot;Risk Factors&quot; in Auris Medical&#39;s Annual Report on Form 20-F for the year ended December 31, 2020, and in Auris Medical&#39;s other filings with the SEC, which are available free of charge on the Securities Exchange Commission&#39;s website at:&nbsp;<a href="http://www.sec.gov/">www.sec.gov</a>. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Auris Medical or to persons acting on behalf of Auris Medical are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Auris Medical does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law.
Investor contact:
<a href="https://www.globenewswire.com/Tracker?data=dW_zWouJYG6LcAWaTKSktNtiuTQ3CkJ7k1dsAKww5UgFEBfOFXC1HBBmSf3_oUuLoevB0fMaxGfRKbnfGQAFsPK0nuzNDBAhQQFrFb2KzSwqOwdwLoz2to0k-ttJ-SKp" target="_blank">investors@aurismedical.com</a>
<hr />
1 Rauch DA et al. Targeting NF-&kappa;B with nanotherapy in a mouse model of adult T-cell leukemia/lymphoma. Nanomaterials 2021, 11(6), 1582.
<img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDUxMTgyMyM0MDA5Njk5ODkjMjAwMDExMg==" style="height:1px; width:1px" /> 
&nbsp;
<a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/3b7ae447-da82-409d-9e38-24c8be95f6bb"><img alt="Primary Logo" src="https://ml-eu.globenewswire.com/media/3b7ae447-da82-409d-9e38-24c8be95f6bb/small/logo-gif.gif" style="height:39px; width:150px" /></a>

Movers

Trading Ideas

EARS

Auris Medical Announces 'Significant Inhibition Of Tumor Growth 'With OligoPhore siRNA Targeting NF-κB In Murine Model Of Adult T-Cell Leukemia / Lymphoma

Greenland Technologies Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) (&quot;Greenland&quot;), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announced a major strategic partnership with Shandong Zhongcha Heavy Industry Machinery Co. (&quot;Shandong&quot;), a multinational heavy machinery and automotive manufacturing company.&nbsp;
<a href="https://mma.prnewswire.com/media/1537212/GTEC_Forklift.html" target="_blank"><img alt="Greenland Technologies Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ" />GTEC</a>), www.gtec-tech.com" src="https://mma.prnewswire.com/media/1537212/GTEC_Forklift.jpg" /> 
The partnership is structured to accomplish two strategic objectives to drive revenue generation and to enhance leadership position as a first mover.&nbsp; First, the companies are joining forces to launch a lithium battery forklift, which utilizes Greenland&#39;s new integrated drivetrain system that will be available for sale in the U.S. by Greenland starting in July 2021.&nbsp; Second, the two strategic partners will combine R&amp;D resources to develop the next stage of lithium powered forklifts to ensure they remain positioned for market leadership over the longer term.
Headquartered in Jinan, Shandong, China, Shandong Zhongcha Heavy Industry Machinery Co. was founded in 2009 through a merger between Weichai Holding Group, Shandong Construction Machinery Group and Shandong Auto Industrial Group.&nbsp; Shandong Heavy Industry has five principal operating subsidiaries: Weichai Holding Group Co., Ltd. (the parent company of Weichai Power), Shantui Construction Machinery Co., Ltd., Shantui Machinery Co., Ltd., Shanzhong Construction Machinery Co., Ltd., and Shandong Auto Industry Group Co., Ltd., Shazhonng Construction Machinery.
Raymond Wang, CEO of Greenland, commented, &quot;This is another major development for our business, as we align with a powerful, well-funded strategic partner with extensive experience and customer relationships in our target markets.&nbsp; We have already spoken with numerous customers with very positive feedback for a lithium battery forklift solution. Importantly, we are confident we can bring our jointly-developed lithium battery powered forklift to market at a price point competitive with legacy acid battery powered vehicles.&nbsp; The competitive price point combined with the fact our vehicle is a safer, cleaner vehicle with a higher customer return on investment than traditional forklifts, gives us a winning market position with high-volume potential.&nbsp; We look forward to working together with Shandong, as we build a mutually successful, long-term partnership.&quot;

GTEC

Greenland Technologies Reports Strategic Partnership With Shandong Heavy Industry, No Terms Disclosed

Align Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative, today announced its first limited-edition product, the Charli D&#39;Amelio x Invisalign&reg; Aligner Case, created exclusively for the Invisalign brand by social media star Charli D&#39;Amelio (@charlidamelio). Over the past year, Charli has been documenting her Invisalign treatment journey, and as an expression of that experience, has designed a special, limited-edition case for Invisalign aligners. 
&nbsp;
The Charli D&#39;Amelio x Invisalign&reg; Aligner Case features a pink exterior, lavender interior, and printed text with Charli&#39;s signature mantra, &quot;All Smiles Here.&quot; A magnetic closure ensures the case stays securely fastened and a textured liner minimizes movement while in transit. Cases will be available for&nbsp;$24.99&nbsp;each and can be purchased from the official Invisalign store:&nbsp;<a href="https://www.invisalignaccessories.com/">https://www.invisalignaccessories.com</a>. The official Invisalign store features the most extensive Invisalign product catalogue, including products and accessories not available elsewhere.
&quot;Our purpose at Align is to transform smiles and change lives, which we have been focused on for more than 20 years, and we recently celebrated our 10 millionth Invisalign smiles milestone,&quot; said Kamal Bhandal, Align Technology vice president, Global Brand and Consumer Marketing. &quot;So, working with an influencer dedicated to bringing smiles to her millions of fans is a natural collaboration. We know teens like Charli have a lot going on in their lives, and we are proud when teens and their parents select an Invisalign-trained doctor to provide Invisalign treatment, a better alternative to metal braces that is both more comfortable and fits into their lifestyle. The limited-edition Charli D&#39;Amelio x Invisalign&reg; Aligner Case is a beautiful testament to our shared goal of sharing smiles.&quot;
The teen icon has been working with the Invisalign brand for the last year. The relationship started as a way to provide Charli with cutting-edge orthodontic treatment to give her a superior smile, while fitting into her active lifestyle.
&quot;I love Invisalign aligners because they let you do you! I had braces in the past, but with Invisalign clear aligners I can live my life without worrying about an emergency orthodontist visit due to broken wires or brackets,&quot; said Charli D&#39;Amelio. &quot;When the Invisalign brand asked if I could create a limited-edition case during the second year of our relationship, I couldn&#39;t wait to design something that reflected my personality for my fans to enjoy!&quot;
Special features of the case include spacing behind the hinge to allow for proper ventilation, so aligners stay fresh between wear. Each case comes with a black Invisalign drawstring pouch to carry personal oral hygiene essentials, such as floss, toothpaste, and travel toothbrush.
To learn more or purchase the limited-edition Charli D&#39;Amelio x Invisalign&reg; Aligner Case, visit&nbsp;<a href="https://www.globenewswire.com/Tracker?data=ioZ5Y6HyffqWTTwEV8BuMwlIiCFEd5X5nhOOLdW2B3f4qGkuzvJm4TZqIlft51Tf_uVXCThIOY7OX3jLkDk0RxE8xHEec4XU8WWcAioVxsM06ttmNSqN9hM8QT-i90oZ" target="_blank">InvisalignAccessories.com</a>&nbsp;or&nbsp;<a href="https://www.globenewswire.com/Tracker?data=DMiro34mDWoLmEVuCw2Kv-H7CQR-LeMG-4LEGfuI0JDOCWg_ZXfgvRqo8kwrO8wGp8lLXzvTBZZ0cuLAvVFAx9MnFhRmn-C-5rrhYUJuMKpkPSfEXfJdO7p3L0PZH_EfA4v-yOMJujaPGG7GObzNPCPX9I1Squ7VOSB_2R_UxpY=" target="_blank">Amazon.com</a>.

ALGN

Align Technology Introduces Limited-Edition Charli D'Amelio x Invisalign Aligner Case

&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3202426-1&amp;h=1098339149&amp;u=http%3A%2F%2Fwww.sabre.com%2F&amp;a=Sabre+Corporation" target="_blank">Sabre Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>), a leading software and technology provider that powers the global travel industry, and Virgin Australia have reaffirmed their long-standing&nbsp;relationship with the renewal of their global distribution agreement.
<a href="https://mma.prnewswire.com/media/322180/sabre_logo.html" target="_blank"><img alt="Sabre logo. (PRNewsFoto/Sabre) (PRNewsFoto/SABRE)" src="https://mma.prnewswire.com/media/322180/sabre_logo.jpg" /> </a>
Under the renewed agreement, Sabre will continue to distribute Virgin Australia flights and services through the Sabre GDS marketplace, ensuring that hundreds of thousands of Sabre-connected agencies will continue to have access to Virgin Australia&#39;s great value products and services.
&quot;Although international borders remain largely closed at the moment, there is a lot of pent-up demand and positivity in the domestic market,&quot; said David Orszaczky, General Manager Digital and Distribution, Virgin Australia. &quot;We&#39;re committed to creating an ecosystem that delivers great-value for customers and ensuring our agency partners can help deliver the many travel experiences we offer in their preferred channel.&quot;
The renewal comes at an exciting time for Virgin Australia and the broader aviation industry, which is beginning to recover from the impacts of COVID-19. Taking flight under new ownership, Virgin Australia is working to evolve and modernise its distribution strategy to further deliver experiences its guests love amidst a fast-changing travel marketplace.
&quot;We are thrilled to reaffirm our longstanding collaboration with Virgin Australia at this important time for the carrier and for the travel industry,&quot; said Rakesh Narayanan, Regional General Manager, Asia Pacific, Travel Solutions, Airline Sales. &quot;Our renewed agreement provides certainty to the travel industry that Virgin Australia&#39;s travel agency content will continue to be available on the Sabre GDS as well as being testament to the commitment of both Virgin Australia and Sabre to providing rich content through our global distribution network.&quot;

SABR

Sabre Reports Renewal Of Distribution Deal With Virgin Australia, No Terms Disclosed

Shares of Facebook, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fb#NASDAQ">FB</a>) are sitting on an important support level. There&rsquo;s a chance they stage some type of rebound, but if the support breaks, they could go into a steep decline.
What To Know: Support is a large concentration of buyers who are looking to pay the same price for shares. In this case, it&#39;s $330.
At support levels, there is more demand for the stock than there is supply. This is why sell-offs end when they reach them.
But when a support level breaks, it means the buyers who created the support have finished or canceled their orders. Either way, they have left the market.
With this demand out of the way, sellers will be forced to accept lower prices for their shares. This could cause a downtrend to form.
See Also: <a href="https://www.benzinga.com/money/how-to-buy-facebook-stock/">How To Buy Facebook Stock</a>
<img alt="fb_10.png" src="https://www.benzinga.com/files/u344550/fb_10.png" style="height:400px; width:640px" />

Long Ideas

Short Ideas

Technicals

Is Facebook's Stock About To Drop?

USA Chicago Fed National Activity Index for May 0.290 vs 0.240 prior reading.

Econ #s

Economics

USA Chicago Fed National Activity Index for May 0.290 vs 0.240 Prior

Scotiabank analyst Ben Isaacson upgrades Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Sector Perform to Sector Outperform and announces $145 price target.

Scotiabank Upgrades Eastman Chemical to Sector Outperform, Announces $145 Price Target

Alset EHome International Shares Continue Higher Above $7 Level After Announcement Of Agreement With Tesla

B. Riley Securities analyst Eric Wold upgrades MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) from Neutral to Buy.

B. Riley Securities Upgrades MarineMax to Buy

<a href="https://uphold.com/en-us">Uphold</a>, a fintech providing investors single-wallet access to cryptocurrencies, fractional U.S. equities, commodities, carbon credits&nbsp;and FX, last week formally announced the launch of smart limit orders.
As part of the development, Benzinga chatted with CEO JP Thieriot.
About: Depending on where you&rsquo;re based, the concept of currency can take on different meanings. That&rsquo;s according to Thieriot who saw the impact of strong and weak currencies, first hand.
&ldquo;That ends up pretty much dictating how your citizenry fares,&rdquo; he explained in a discussion on currency devaluation and his motives for getting involved in finance. &ldquo;Why would anybody pay their taxes when the interest rates and penalties that would be put on them won&rsquo;t keep pace with devaluation.&rdquo;
Thieriot&rsquo;s comments come as countries like El Salvador opt to adopt cryptocurrencies, like bitcoin, as legal tender. The development would save Salvadorans money in banking, remove politics from economics, and allow the country to build a modern financial ecosystem.
In building a business that empowers emerging financial landscapes to grow, Thieriot tapped into his learnings from institutions like Hambrecht &amp; Quist, and partnered with Halsey Minor, the founder of technology company CNET, among others, to launch Uphold.
Founded in 2014, Uphold is a digital wallet and trading platform that makes cryptocurrencies and other assets affordable and accessible for everyone. The company is a pioneer, allowing users to trade directly between supported asset classes and send any currency, to virtually anyone, anywhere.
<a href="https://www.benzinga.com/money/best-crypto-wallet/">Best Crypto Wallets</a>
Product: There are two sides to the business.
The first consumer-facing side collapses different accounts &ndash; bank, commodity, securities &ndash; into a convenient wallet from which users can invest and trade. There&rsquo;s also lending, borrowing, spending, and sending, Thieriot notes; &ldquo;there&rsquo;s no reason why those things should be segregated or subject to anachronistic settlement times and 9-to-5 limitations.&rdquo;
In the simplest way, Uphold works off the premise that banks are not going to be able to step into a world where millennials are interested in staking and accessing decentralized finance, or DeFi.
&ldquo;These are all sort of new things that traditional financial services do not address. So, for us, it&rsquo;s sort of a blank canvas.&rdquo;
The company&rsquo;s core product portfolio consists of automated trade through AutoPilot, the Uphold debit card through which users can pay in crypto or gold, as well as earn cashback and rewards, in addition to multi-asset fractional trading of equities and currencies.
A differentiator, Thieriot notes, is Uphold&rsquo;s Anything to Anything feature which enables one-step trading capabilities.
&ldquo;All of our competitors operate in the vernacular of trading pairs, a concept, right out of the gate, that&rsquo;s probably great for professional traders,&rdquo; he said. &ldquo;The Anything to Anything concept is not only far more graspable for most people. Rather than selling Google to get dollars and then using those dollars to buy Apple, you can send somebody Apple, on your debit card.&rdquo;
Recent Events: Uphold announced the launch of smart limit orders that allow users to place up to 50 limit orders, simultaneously, without having to lock in funds at the time the order is placed.
&ldquo;The concept is that if you have a certain balance, you don&rsquo;t need to choose one limit order, or create a hierarchy based on your balance,&rdquo; Thieriot explained. &ldquo;You can put out [numerous] limit orders and the first one that executes hits.&rdquo;
Basically, the feature enables Uphold users optionality, or a way to get in and out at better prices without committing capital at the outset, Thieriot said.
&ldquo;You have $1000 and you&rsquo;re not sure what you prefer &ndash; either bitcoin at $36,000 or ethereum at $2,400 &ndash; if you put both [orders] out there, whichever hits first is first and the rest are canceled.&rdquo;
Innovation Outlook: No later than the first quarter of 2022, Uphold users, across nearly all countries the company operates in, will have fractional access to over 3,500 stocks and ETFs, options, margin, and short-selling.
&ldquo;Most brokers are introducing brokers that rely on clearing firms to do all the books and records. We&rsquo;re omnibus, so it allows us to handle equities in essentially the same way we handle cryptos and fiat.&rdquo;
This dynamic is what enabled Uphold to innovate much quicker. Adding, Uphold users, in addition to improved staking and DeFi capabilities, will also see new payments tech that enables them to send money and pay people who are not one of Uphold&rsquo;s over seven million members.

Fintech news covering the emerging Financial Technology services sector

Fintech

Interview

Fintech Spotlight: Meet Uphold, A More Versatile Home For Your Finances

GROY

Gold Royalty Corp Shares Halted On Code News Pending

Morgan Stanley analyst Stephen Byrd maintains Sempra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) with a Equal-Weight and raises the price target from $157 to $158.

Morgan Stanley Maintains Equal-Weight on Sempra Energy, Raises Price Target to $158

Morgan Stanley analyst Stephen Byrd maintains Spire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) with a Equal-Weight and raises the price target from $78 to $84.

Morgan Stanley Maintains Equal-Weight on Spire, Raises Price Target to $84

Morgan Stanley analyst Stephen Byrd maintains SunPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) with a Underweight and raises the price target from $21 to $22.

SPWR

Morgan Stanley Maintains Underweight on SunPower, Raises Price Target to $22

51job, Inc. (Nasdaq:&nbsp;JOBS)&nbsp;(&quot;51job&quot;, or the &quot;Company&quot;), a leading provider of integrated human resource services in&nbsp;China, announced today that it has entered into a definitive Agreement and Plan of Merger (the &quot;Merger Agreement&quot;) with Garnet Faith Limited, an exempted company with limited liability incorporated under the law of the&nbsp;Cayman Islands&nbsp;(&quot;Merger Sub&quot;), pursuant to which, and subject to the terms and conditions thereof, Merger Sub will merge with and into the Company&nbsp;(the &quot;Merger&quot;)&nbsp;with the Company being the surviving company (&quot;Surviving Company&quot;), in a transaction implying an equity value of the Company of approximately&nbsp;US$5.7 billion&nbsp;in which the Company will be acquired by a consortium of investors (the &quot;Consortium&quot;).
Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the &quot;Effective Time&quot;), each common share, par value&nbsp;US$0.0001&nbsp;per share, of the Company (each, a &quot;Common Share&quot; or a &quot;Share&quot;) issued, outstanding and not represented by American depositary shares of the Company (each, an &quot;ADS,&quot; representing one Common Share) immediately prior to the Effective Time, other than the Excluded Shares, the Continuing Shares and the Dissenting Shares (each as defined in the Merger Agreement), will be cancelled and cease to exist, in exchange for the right to receive&nbsp;US$79.05&nbsp;in cash per Share without interest (the &quot;Per Share Merger Consideration&quot;), and each outstanding ADS, other than ADSs representing Excluded Shares and Continuing Shares, together with each Share represented by such ADS, will be cancelled in exchange for the right to receive&nbsp;US$79.05&nbsp;in cash per ADS without interest (the &quot;Per ADS Merger Consideration&quot; and, together with the Per Share Merger Consideration, the &quot;Merger Consideration&quot;).

JOBS

51job, Inc. Enters into a Definitive Agreement for Going-Private Transaction

Last week&rsquo;s sell-off in the market was driven mostly by the financial sector.
But now shares of Microsoft Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) have reached a critical resistance level. If they can&rsquo;t break through and they end up moving lower again, it could pull down the technology sector and maybe the rest of the market along with it.
See Also: <a href="https://www.benzinga.com/news/21/06/21629405/if-you-invested-1-000-in-microsoft-when-satya-nadella-became-ceo-heres-how-much-youd-have-now?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+benzinga%2Fnews+%28Channels+-+News%29">If You Invested $1,000 In Microsoft When Satya Nadella Became CEO, Here&#39;s How Much You&#39;d Have Now</a>
Microsoft&#39;s stock ran into a wall of sellers in April when it reached the $261 level and a&nbsp;sell-off followed. Now, the stock has reached the $261 level once again.
f it can break through this time, it will be bullish for the broader markets. But if it can, there&rsquo;s a good chance that the move lower in the markets will probably continue.
<img alt="msft_2.png" src="https://www.benzinga.com/files/u344550/msft_2.png" style="height:400px; width:640px" />

MSFT

Can Microsoft's Stock Save The Market?

Hill International&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIL#NYSE">HIL</a>), delivering the infrastructure of change, announced today it has been awarded a contract by Aldar Projects LLC, the project delivery arm of UAE real estate developer Aldar Properties, to provide project management services for infrastructure upgrades in Abu Dhabi. 
&nbsp;
The project consists of two distinct elements: The Zayed Link Road and Tal Moreeb Road. The Zayed Link Road project will refurbish and double the capacity of the existing link road between the E11 highway and the Madinat Zayed military airfield near the city of Madinat Zayed in the Al Dhafra Region. In total approximately 50 km (32 miles) of road will be converted from existing single carriageway (one lane in each direction) to dual carriageway (two lanes in each direction with central median). The existing carriageway will also be refurbished. The Tal Moreeb Road project will construct a new dual carriageway from Liwa to the Tal Moreeb dune area to replace the existing road. The road length is approximately 22 km (14 miles). Both elements are scheduled for completion in late 2022.
&quot;Aldar is a long-term client for Hill International in the Middle East and we are privileged to have been given the opportunity to expand our professional services to cover this important project,&quot; said Abdo Kardous, Regional President for the Middle East of Hill International.
&quot;Hill has a well-earned reputation for managing high-profile developments throughout the Middle East,&quot; says Hill Chief Executive Officer Raouf S. Ghali. &quot;This important infrastructure upgrade for Aldar is a continuation of this work, and we look forward to driving success throughout the project process.&quot;

Hill International Awarded Contract by Leading UAE Real Estate Developer Aldar Properties to Oversee Infrastructure Upgrades in Abu Dhabi

AgraFlora Organics International Inc.&nbsp;(CSE:&nbsp;AGRA) (OTC:<a class="ticker" href="/stock/AGFAF#OTC">AGFAF</a>) <a href="http://www.globenewswire.com/news-release/2020/11/23/2131824/0/en/AgraFlora-s-Delta-Greenhouse-Receives-Agriculture-Loan.html">said its joint venture</a>&nbsp;venture with the Houwelings Group &mdash;&nbsp;Propagation Services Canada Inc. &mdash; obtained an agriculture loan.

Cannabis company plans to use the loan to present its cannabis on the market and further support Phase 1 of its cultivation strategy.

Propagation Services Canada Inc. is the company&rsquo;s flagship cultivation asset based in Delta, British Columbia, which is now set to gain $5 million as part of the loan. This will enable the company to finance cultivation sectors, and for Propagation Services Canada to introduce their first crop to market in the first quarter of 2021.

More details regarding the terms of the loan weren&#39;t disclosed.

According to the AgraFlora board, a fully funded Phase 1 cultivation strategy allows the company to deliver high potency cannabis strains in 2021.

&ldquo;As partners at PSC, we have full confidence in the Houwelings family&#39;s ability to achieve this strategy, given their long history of high-quality agricultural production in low-cost environments, as well as the healthy condition of our award winning genetics,&quot; the board states.

Courtesy image

Cannabis

Financing

Media

AgraFlora Secures Agriculture Loan To Support Phase 1 Cultivation Strategy

<h4>GAINERS:</h4>

<ul>
	<li>MedMen Enterprises Inc - Class B (Sub Voting) (OTCQX:<a class="ticker" href="/stock/MMNFF#OTCQX">MMNFF</a>) shares closed up&nbsp;60.85% at $&nbsp;0.27</li>
	<li>Singlepoint Inc (OTC:<a class="ticker" href="/stock/SING#OTC">SING</a>) shares closed up 48.28% at&nbsp;$0.03</li>
	<li>WeedMD Inc (OTCQX:<a class="ticker" href="/stock/WDDMF#OTCQX">WDDMF</a>) shares closed up 41.90% at&nbsp;$0.38</li>
	<li>Medical Marijuana Inc (OTC:<a class="ticker" href="/stock/MJNA#OTC">MJNA</a>) shares closed up 40.44% at&nbsp;%0.06</li>
	<li>Golden Leaf Holdings Ltd (OTCQB:<a class="ticker" href="/stock/GLDFF#OTCQB">GLDFF</a>) shares closed up 27.81% at $0.05</li>
	<li>The Supreme Cannabis Company Inc (OTCQX:<a class="ticker" href="/stock/SPRWF#OTCQX">SPRWF</a>) shares closed up 25% at&nbsp;$0.23</li>
	<li>4Front Ventures Corp (Sub Voting) (OTCQX:<a class="ticker" href="/stock/FFNTF#OTCQX">FFNTF</a>) shares closed up 24.14% at&nbsp;$1.440</li>
	<li>Terra Tech Corp (OTCQX:<a class="ticker" href="/stock/TRTC#OTCQX">TRTC</a>) shares closed up 17.07% at&nbsp;$0.34</li>
	<li>Canopy Rivers Inc (Sub Voting) (OTC:<a class="ticker" href="/stock/CNPOF#OTC">CNPOF</a>) shares closed up 15.80% at&nbsp;$5.13</li>
	<li>Smart Cannabis Corp - Class A (OTC:<a class="ticker" href="/stock/SCNA#OTC">SCNA</a>) shares closed up $13.92 at $0.02</li>
	<li>Item 9 Labs Corp (OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 11.38% at&nbsp;$3.23</li>
	<li>Jushi Holdings Inc.&nbsp;- Class B (Sub Voting) (OTCQB:<a class="ticker" href="/stock/JUSHF#OTCQB">JUSHF</a>) shares closed up 10.80% at&nbsp;$8.59</li>
	<li>KushCo Holdings Inc (OTCQX:<a class="ticker" href="/stock/KSHB#OTCQX">KSHB</a>) shares closed up 10.32% at&nbsp;$1.71</li>
</ul>

<h4>LOSERS:</h4>

<ul>
	<li>AgraFlora Organics International Inc (OTC:<a class="ticker" href="/stock/AGFAF#OTC">AGFAF</a>) shares closed down 9.71% at $0.03</li>
	<li>Stem Holdings Inc (OTCQX:<a class="ticker" href="/stock/STMH#OTCQX">STMH</a>) shares closed down 9.70% at&nbsp;$0.75</li>
	<li>Zelira Therapeutics Limited (OTCQB:<a class="ticker" href="/stock/ZLDAF#OTCQB">ZLDAF</a>) shares closed down 9.56% at&nbsp;$0.07</li>
	<li>MGC Pharmaceuticals Ltd (OTC:<a class="ticker" href="/stock/MGCLF#OTC">MGCLF</a>) shares closed down 9.37% at&nbsp;$0.03</li>
	<li>Reliq Health Technologies Inc (OTC:<a class="ticker" href="/stock/RQHTF#OTC">RQHTF</a>) shares closed down 9.08% at $0.53</li>
	<li>Power REIT (MD) (NYSE:<a class="ticker" href="/stock/PW#NYSE">PW</a>) shares closed down&nbsp;6.14% at $35.45</li>
	<li>Sundial Growers Inc. (NCM:SNDL) shares closed down 4.96% at&nbsp;$1.15</li>
	<li>Aurora Cannabis Inc. (OTC:<a class="ticker" href="/stock/ACB#OTC">ACB</a>) shares closed down&nbsp;$4.95 $13.07</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Penny Stocks

Small Cap

After-Hours Center

Cannabis Stock Gainers And Losers From February 4, 2021

<h4>GAINERS:</h4>

<ul>
	<li>Invictus MD Strategies Corp Class A (OTC:<a class="ticker" href="/stock/IVITF#OTC">IVITF</a>) shares closed up 110.67% at $0.08</li>
	<li>Harvest One Cannabis Inc (OTCQB:<a class="ticker" href="/stock/HRVOF#OTCQB">HRVOF</a>) shares closed up 105.11% at $0.39</li>
	<li>WEED Inc (OTCQB:<a class="ticker" href="/stock/BUDZ#OTCQB">BUDZ</a>) shares closed up 100.98% at $2.05</li>
	<li>Smart Cannabis Corp - Class A (OTC:<a class="ticker" href="/stock/SCNA#OTC">SCNA</a>) shares closed up 97.07% at $0.04</li>
	<li>Medical Marijuana Inc (OTC:<a class="ticker" href="/stock/MJNA#OTC">MJNA</a>) shares closed up 69.90% at $0.17</li>
	<li>Tilray Inc. (NGS:TLRY) shares closed up 50.91% at $63.91 <a href="https://www.benzinga.com/node/19599265">Learn More</a></li>
	<li>Zynerba Pharmaceuticals Inc. (NSD:ZYNE) shares closed up 46.94% at $8.75</li>
	<li>AgraFlora Organics International Inc (OTC:<a class="ticker" href="/stock/AGFAF#OTC">AGFAF</a>) shares closed up 43.89% at $0.06</li>
	<li>General Cannabis Corp (OTCQB:<a class="ticker" href="/stock/CANN#OTCQB">CANN</a>) shares closed up 39.85% at $1.86</li>
	<li>Organigram Holdings Inc. (NGS:OGI) shares closed up 37.30% at $6.00</li>
	<li>WeedMD Inc (OTCQX:<a class="ticker" href="/stock/WDDMF#OTCQX">WDDMF</a>) shares closed up 35.00% at $0.73</li>
	<li>MedMen Enterprises Inc (OTCQX:<a class="ticker" href="/stock/MMNFF#OTCQX">MMNFF</a>) shares closed up 33.93% at $1.29</li>
	<li>PharmaCielo Ltd. (OTCQX:<a class="ticker" href="/stock/PCLOF#OTCQX">PCLOF</a>) shares closed up 28.42% at $2.07</li>
	<li>Terra Tech Corp (OTCQX:<a class="ticker" href="/stock/TRTC#OTCQX">TRTC</a>) shares closed up 22.59% at $0.70</li>
	<li>Aurora Cannabis Inc. (NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed up 21.20% at $18.92</li>
	<li>Neptune Wellness Solutions Inc. (NCM:NEPT) shares closed up 20.69% at $3.15&nbsp;<a href="https://www.benzinga.com/markets/cannabis/21/02/19594365/neptune-wellness-shares-spike-ahead-of-sprout-foods-deal">Learn More</a></li>
	<li>MariMed Inc (OTCQX:<a class="ticker" href="/stock/MRMD#OTCQX">MRMD</a>) shares closed up 20.42% at $0.95</li>
	<li>Fire &amp; Flower Holdings Corp (OTCQX:<a class="ticker" href="/stock/FFLWF#OTCQX">FFLWF</a>) shares closed up 20.36% at $1.04</li>
	<li>The Supreme Cannabis Company Inc (OTCQX:<a class="ticker" href="/stock/SPRWF#OTCQX">SPRWF</a>) shares closed up 17.91% at $0.40</li>
	<li>Aleafia Health Inc. (OTCQX:<a class="ticker" href="/stock/ALEAF#OTCQX">ALEAF</a>) shares closed up 16.36% at $1.00</li>
	<li>Planet 13 Holdings Inc (OTCQX:<a class="ticker" href="/stock/PLNHF#OTCQX">PLNHF</a>) shares closed up 16.01% at $8.19</li>
	<li>NIC Inc. (NGS:EGOV) shares closed up 15.67% at $34.48</li>
	<li>Cronos Group Inc. (NSD:CRON) shares closed up 14.42% at $15.55</li>
	<li>Aphria Inc. (NGS:APHA) shares closed up 10.74% at $26.30</li>
	<li>Village Farms International Inc. (NCM:VFF) shares closed up 10.18% at $19.37</li>
	<li>HEXO Corp. (NYSE:<a class="ticker" href="/stock/HEXO#NYSE">HEXO</a>) shares closed up 7.87% at $10.28</li>
	<li>Green Thumb Industries Inc (Sub Voting) (OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) shares closed up 7.55% at $38.45</li>
</ul>

<h4>LOSERS:</h4>

<ul>
	<li>CBD Unlimited Inc (OTC:<a class="ticker" href="/stock/EDXC#OTC">EDXC</a>) shares closed down 12.64% at $0.20</li>
	<li>Hemp Inc (OTC:<a class="ticker" href="/stock/HEMP#OTC">HEMP</a>) shares closed down 12.03% at $0.02</li>
	<li>Skylight Health Group Inc Com (OTC:<a class="ticker" href="/stock/SHGFF#OTC">SHGFF</a>) shares closed down 7.86% at $1.29</li>
	<li>Tetra Bio-Pharma Inc (OTCQB:<a class="ticker" href="/stock/TBPMF#OTCQB">TBPMF</a>) shares closed down 5.07% at $0.26</li>
	<li>Cannabis Strategic Ventures (OTC:<a class="ticker" href="/stock/NUGS#OTC">NUGS</a>) shares closed down 4.76% at $0.40</li>
	<li>Cannabics Pharmaceuticals Inc (OTCQB:<a class="ticker" href="/stock/CNBX#OTCQB">CNBX</a>) shares closed down 4.53% at $0.51</li>
	<li>Jushi Holdings Inc. - Class B (Sub Voting) (OTCQB:<a class="ticker" href="/stock/JUSHF#OTCQB">JUSHF</a>) shares closed down 4.07% at $8.25</li>
	<li>BellRock Brands Inc (Sub Voting) (Greys:DXBRF) shares closed down 3.70% at $0.13</li>
	<li>Turning Point Brands Inc. (NYSE:<a class="ticker" href="/stock/TPB#NYSE">TPB</a>) shares closed down 3.33% at $54.81</li>
	<li>Zenabis Global Inc. (OTC:<a class="ticker" href="/stock/ZBISF#OTC">ZBISF</a>) shares closed down 2.33% at $0.15</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From February 10, 2021

<h4>Ignite&nbsp;Strengthens Board, Leadership And Executive Team</h4>

Dan Bilzerian&rsquo;s IGNITE International Brands&nbsp;Ltd. (CSE:<a class="ticker" href="/stock/BILZ#CSE">BILZ</a>) (OTCQX:<a class="ticker" href="/stock/BILZF#OTCQX">BILZF</a>)&nbsp;<a href="http://www.businesswire.com/news/home/20210308005185/en/IGNITE-INTERNATIONAL-BRANDS-Announces-the-Appointment-of-a-New-Director-and-Four-New-Members-to-its-Senior-Management-Team">has appointed</a> Vered Elkouby Nisim to its board of directors.

Nisim brings vast marketing experience, having worked with JH Design Group, which specializes in licensed products for the NFL, NBA, MLB, NHL, NASCAR, and Marvel, to name a few. She is also Brellascope&rsquo;s founder.

The Vaughan, Ontario-based company also named&nbsp;four new executives.

Paul Holden was tapped to serve as general counsel and corporate secretary. Prior to this, he worked at Molson Coors, holding several legal positions.

Lee Probst, a sales and&nbsp;marketing expert, was tapped to serve as vice president, sales.

Manuel Gonzalez is poised to join Ignite as vice president, international business development in April. Gonzales spent over two decades building global distribution networks for both apparel and vape companies.

Zach Gleason, who will serve as vice president, distribution, is a former president at&nbsp;Higher Connection.

<h4>AgraFlora Organics Names New CEO</h4>

AgraFlora Organics International Inc. (CSE:<a class="ticker" href="/stock/AGRA#CSE">AGRA</a>) (OTC:<a class="ticker" href="/stock/AGFAF#OTC">AGFAF</a>) <a href="http://www.globenewswire.com/news-release/2021/03/08/2188833/0/en/AgraFlora-Appoints-Elise-Coppens-as-New-CEO-and-Director-to-Implement-the-Next-Phase-of-its-Corporate-Strategy.html">has named</a> Elise Coppens its new CEO and board member.

Previously, she served as Bloomera&rsquo;s president, marketing director for Aurora Cannabis, and the director of international sales for Ample Organics.

AgraFlora&rsquo;s former CEO, Chairman, and Corporate Secretary, Brandon Boddy, who opted to step down from the position, welcomed Coppens, highlighting he is &ldquo;excited to have someone of her calibre take over the leadership of this Company.&rdquo;

In addition, Vancouver company also hired Meadowbank Strategic Partners Inc., a Calgary-based corporate consultancy company.

AgraFlora confirmed that its joint venture with the Houwelings Group &mdash; Propagation Services Canada Inc. &mdash;&nbsp;<a href="http://www.benzinga.com/markets/cannabis/20/11/18510623/agraflora-secures-agriculture-loan-to-support-phase-1-cultivation-strategy">has secured financing</a> to support Phase 1 of its cultivation strategy through an agriculture loan.

<h4>Body And Mind Appoints Alexis Podesta To The Board Of Directors</h4>

Body and Mind Inc. (CSE:<a class="ticker" href="/stock/BAMM#CSE">BAMM</a>) (OTCQB:&nbsp;<a href="http://www.benzinga.com/stock/bmmj/#/OTCQB">BMMJ</a>) has tapped a seasoned cannabis expert Alexis Podesta to serve as a director.

During her career, she held several positions in the public as well as the private sector.

She has managed the California Business, Consumer Services, and Housing Agency under both Governor Gavin Newsom and Governor Edmund G. Brown, Jr.

&quot;Alexis brings a wealth of board, management and cannabis experience to Body and Mind, and we look forward to increasing the depth and experience of our board,&quot; the company&#39;s CEO Michael Mills <a href="http://www.prnewswire.com/news-releases/body-and-mind-strengthens-board-with-veteran-cannabis-executive-301242332.html#financial-modal">noted</a> Monday.

The Vancouver company <a href="http://www.benzinga.com/markets/cannabis/20/12/18822183/earnings-roundup-c21-investments-body-and-mind-cbd-of-denver">recently</a> reported its fourth-quarter revenue went up by 106% sequentially to $2.17 million. The company generated $6.23 million in revenue for the whole year, and record system-wide managed revenue of $17.6 million.

<h4>SV Labs Taps Graham Orriss As New CEO</h4>

SV Labs, a manufacturer of natural beauty and personal care,&nbsp;<a href="http://www.businesswire.com/news/home/20210308005055/en/SV-Labs-Announces-Graham-Orriss-as-New-Chief-Executive-Officer">has appointed</a> Graham Orriss to serve as its CEO.

Orriss brings over three decades of executive experience, including a vast knowledge in supply chain and operations leadership.

&quot;Graham&#39;s impressive track record in the BPC industry make him the ideal leader for SV Labs as we embark on the next phase of growth for the company,&quot; commented Scott Potter, chairman of SV Labs and managing partner of San Francisco Equity Partners

The San Francisco company &mdash; also San Francisco Equity Partners&#39; portfolio company &mdash;&nbsp;manufactures bath salts, skincare, body care, and CBD topicals.

<h4>Red Light Holland Welcomes Glenn Cowan To Its Advisory Board</h4>

Psychedelics company Red Light Holland Corp. (CSE:<a class="ticker" href="/stock/TRIP#CSE">TRIP</a>) has hired a veteran of the Canadian Special Operations Forces Command (CANSOFCOM), Glenn Cowan, to its advisory board.

Cowan, who joins Bruce Linton and other seasoned experts, is the founder of One 9 Investments Inc, Psychedelic Finance <a href="http://www.psychedelicfinance.com/articles/red-light-holland-engages-former-canadian-special-operations-forces-officer-glenn-cowan-founder-of-one-9-investments-to-advisory-board">reports</a>.

He explained that he is &quot;intimately aware of the physical and psychological stressors that our servicemen and women face on a daily basis and in retirement.&quot;

&quot;I was introduced to the, in my opinion, positive benefits of psychedelics and microdosing during my own journey of adapting to life after the military, and now as a tech investor in venture capital, I&#39;ve come to appreciate some of the best technological innovation is naturally occurring,&quot; Cowan disclosed Friday.

Movers & Shakers

General

Cannabis Movers & Shakers: Ignite, AgoraFlora, B&M, SV Labs, Red Light Holland

Phyto Extractions Announces Departure Of Interim CEO

Phyto Extractions Inc., formerly known as Adastra Labs Holdings Ltd., (CSE:<a class="ticker" href="https://www.benzinga.com/stock/XTRX#CSE">XTRX</a>) (FRA: D2EP), said last Friday it had parted ways with J. Scott Munro, the company&rsquo;s interim CEO and director.

Munro, who said he wanted to pursue &ldquo;new external ventures,&rdquo; will be replaced with a new permanent candidate.

Donald Dinsmore, chief operating officer of the British Columbia-based company, said that during Munro&rsquo;s tenure Phyto Extractions had seen &quot;vast improvements across operations and the financial health of the company.&rdquo;

Mark Shamber Joins HERBL As CFO

California-based cannabis distributor and supplier HERBL has tapped Mark Shamber to oversee its financial department.

Shamber brings over thirty years of finance experience in the food and grocery supply industry, the company reported Monday.

Previously, Shamber served as CFO at SpartanNash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPTN#NASDAQ">SPTN</a>) and was senior vice president, CFO, and treasurer at United Natural Foods, Inc.

HERBL&#39;s CEO Mike Beaudry is looking forward to working with Shamber, now that the company is &ldquo;at a distinct growth stage as the cannabis market matures.&rdquo;

The company has been reinforcing its leadership team over the past period. In February, Tom Grillea <a href="https://www.benzinga.com/markets/cannabis/21/02/19508470/cannabis-movers-shakers-cb1-capital-copperstate-farms-the-ideation-lab-herbl-pure-harvest">opted to join</a> HERBL as the new chief revenue officer, ahead of the <a href="https://www.benzinga.com/markets/cannabis/21/03/20011884/cannabis-movers-shakers-nusachi-apwc-nabis-amco-wslcb-veritas-vinergy-shield-compliance-biosteel">appointment</a> of Josh Held as the new chief strategy officer.

Treez Names Shon Wedde VP Of Engineering

Treez, a seed-to-sale and cannabis retail software platform, said Monday it has welcomed Shon Wedde as vice president of engineering.

Wedde has over two decades of engineering experience, having worked at Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), RightNow Technologies, Aspect Communications, and Janna Systems. He also founded three startups.

John Yang, Treez CEO, is reportedly excited that Wedde agreed to join the company because his &quot;expertise will undoubtedly strengthen our world-class engineering operations.&quot;

Based in Oakland, California, the company <a href="https://www.benzinga.com/markets/cannabis/20/09/17564893/treez-secures-secures-13m-in-funding-in-series-b-round">raised</a> some $13 million in September through a Series B Investment Round led by Intrinsic Capital Partners.

Treez utilized the proceeds to enter into legal state retailers for business-to-consumer (B2C) and business-to-business (B2B) trading.

Fyllo Names New CFO, CLO, And Head Of People

Cannabis technology platform Fyllo announced Tuesday that it had strengthened its leadership team by welcoming Mamta Patel, Travis Moyer and Tracey Felter into its ranks.

Patel, who agreed to oversee Fyllo&#39;s finance department, brings vast executive experience gained from having served as executive director of finance, business developmenta and corporate development at OneSource Virtual and as well as Freeman Spogli.

Moyer, an attorney and veteran cannabis executive, will serve as chief legal officer at the Chicago-based Fyllo. Previously he was vice president of business development at Curaleaf Holdings Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>).

Felter, before joining Fyllo, worked as head of human resources for The Media eXchange, a Chicago start-up.

&quot;These are three critical roles that will enable Fyllo to aggressively scale across the cannabis sector as well as other highly regulated industries,&quot; Chad Bronstein, CEO and co-founder of Fyllo, said.

Auxly Names Andrea Fraser As Chief People Officer

Cannabis-focused CPG company, Auxly Cannabis Group Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTCQX">CBWTF</a>), has tapped Andrea Fraser to serve as chief people officer.

Fraser has vast knowledge of leading people as well as culture strategies and initiatives for CPG and digital marketing companies. Prior to this, she was director of global human resources at Tilray Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>).

In her new role, Fraser will oversee the company&rsquo;s human resources department.

&ldquo;We believe she is the right leader in helping us continue to build an engaged, inclusive, and high-performing culture at Auxly, which will be vital for us as we move forward in executing on our corporate growth strategy in 2021 and beyond,&rdquo; Auxly CEO Hugo Alves&nbsp;said Wednesday.

AgraFlora Organics Taps Fiona Fitzmaurice To Serve As CFO

AgraFlora Organics International Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRA#CSE">AGRA</a>) (Frankfurt: PU31) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AGFAF#OTC">AGFAF</a>) disclosed Wednesday it has appointed Fiona Fitzmaurice as its new CFO.

Fitzmaurice, who succeeds former CFO Peter Nguyen, has more than 14 years of experience in accounting and financial control.

She is a Chartered Professional Accountant who served with both private companies and public issuers.

&ldquo;On behalf of the Board of Directors, I am pleased to welcome Fiona to AgraFlora&rsquo;s management team as we continue to evolve the Company&rsquo;s streamlined corporate strategy and execute on our near-term goal of generating revenues from our core assets,&rdquo; said Elise Coppens, CEO of AgraFlora.

Viridis Laboratories Hires Another Scientist

Cannabis testing facility Viridis Laboratories has hired an additional scientist at its Lansing location.

David Walls, who has extensive knowledge in organic chemistry, data collection and laboratory procedures, will be responsible for testing cannabis samples.

&ldquo;Scientists on our staff play a key role in performing cutting-edge accurate testing that helps cannabis businesses provide high-quality and safe products to Michigan consumers,&rdquo; Viridis CEO Greg Michaud said Wednesday.

M&aacute;s contenido sobre <a href="https://elplanteo.com/que-es-la-marihuana/">cannabis</a> en Espa&ntilde;ol en El Planteo.

Photo by <a href="https://unsplash.com/@daconja?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">David Gabrić</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

Entrepreneurship

Cannabis Movers & Shakers: Phyto, HERBL, Treez, Fyllo, Auxly, AgraFlora, Viridis

AGFAF

ALEAF

BILZF

BUDZ

CANN

CBWTF

CNBX

CNPOF

CSE:AGRA

CSE:BAMM

CSE:BILZ

CSE:TRIP

CSE:XTRX

CURLF

EDXC

FFLWF

FFNTF

GLDFF

GTBIF

HEMP

HEXO

HRVOF

INLB

IVITF

JUSHF

KSHB

MGCLF

MJNA

MMNFF

MRMD

NUGS

ORCL

PCLOF

PLNHF

RQHTF

SCNA

SHGFF

SING

SPRWF

SPTN

STMH

TBPMF

TLRY

TRTC

WDDMF

ZBISF

ZLDAF

Agraflora Organics appoints Elise Coppens as CEO and Director

Canopy Growth and The Supreme Cannabis Company have entered into a definitive arrangement agreement under which Canopy will acquire all of Supreme Cannabis' issued and outstanding common shares in a transaction valued at approximately $435M.

Rising High: Canopy Growth To Acquire The Supreme Cannabis Company In $435M Deal

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s been a few days since OrganiGram (NASDAQ:<a href="https://investorplace.com/stock-quotes/ogi-stock-quote/">OGI</a>) announced it would acquire Edible &amp; Infusions Corporation (EIC) for <a href="https://financialpost.com/cannabis/canadas-organigram-buys-cannabis-edibles-maker-to-tap-red-hot-demand">$28 million</a> in OGI stock. 
<div>
		<img src="https://investorplace.com/wp-content/uploads/2021/02/marijuana-cannabis-stocks-1600-300x169.png" alt="marijuana stocks Hand gently holding rich soil for his marijuana plants" width="300" height="169" />
<div>Source: Jetacom Autofocus / Shutterstock.com</div>
</div>
The move adds to the New Brunswick-based cannabis producer&rsquo;s Western Canadian footprint, both in terms of products offered and manufacturing operations.
&ldquo;<a href="https://investors.organigram.ca/organigram-acquires-soft-chew-manufacturer-edibles-infusions-corporation-a-cannabis-processor">Diversifying our manufacturing</a> and R&amp;D base gives us increased ability to fast-track our near-term commercial plans as well as expand our R&amp;D efforts in addition to those already destined for the Centre of Excellence in connection with BAT,&rdquo; OrganiGram&rsquo;s press release stated.
Note: For those unfamiliar, BAT is short for&nbsp;British American Tobacco&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/bat-stock-quote/">BAT</a>). BAT <a href="https://www.theglobeandmail.com/business/article-organigram-shares-soar-after-global-giant-british-american-tobacco/" target="_blank">owns 20%</a> of OrganiGram.
<ul>
<li>
				<a href="https://investorplace.com/2021/04/7-safe-stocks-to-buy-for-uncertain-times/"> 
					7 Safe Stocks to Buy for Uncertain Times				</a>
			</li>
</ul>
Investors haven&rsquo;t jumped on the OrganiGram bandwagon as a result of the deal&rsquo;s announcement. As I write this at the end of the first full work week in April, OGI stock has fallen more than 10%.&nbsp;
I think the move makes a lot of sense. Here&rsquo;s why.&nbsp;
<h3>Canada&rsquo;s a Big Place</h3>
Have you ever driven across Canada? I have. In fact, I did the <a href="https://www.google.com/search?q=Toronto+to+Vancouver+distance+miles&amp;rlz=1C1SQJL_enCA831CA831&amp;sxsrf=ALeKk02LPrRVVP2jV6T1s2niHYnWwPa3tQ%3A1617977688332&amp;ei=WGFwYN_TE-HT5NoPqPKe4Aw&amp;oq=Toronto+to+Vancouver+distance+miles&amp;gs_lcp=Cgdnd3Mtd2l6EAMyAggAOgcIABBHELADOgQIABBDOgYIABAWEB5QiThYgERg-kRoAXACeACAAYcCiAHBB5IBBTAuNS4xmAEAoAEBqgEHZ3dzLXdpesgBCMABAQ&amp;sclient=gws-wiz&amp;ved=0ahUKEwjf3_fKrPHvAhXhKVkFHSi5B8wQ4dUDCA0&amp;uact=5">Vancouver to Toronto leg</a> (2,718 miles) in late January, right about the time Canadian winters get real nasty. I completed the coast-to-coast experience when we moved to Halifax in February 2018. That was a more leisurely <a href="https://www.google.com/search?q=Toronto+to+Halifax+distance+miles&amp;rlz=1C1SQJL_enCA831CA831&amp;sxsrf=ALeKk03Tor6pSvHH8bBjN1qWk2oZuobPiw%3A1617977698275&amp;ei=YmFwYMemEMaw5NoPmoKmqAY&amp;oq=Toronto+to+Halifax+distance+miles&amp;gs_lcp=Cgdnd3Mtd2l6EAMyBQgAEM0CMgUIABDNAjoHCAAQRxCwAzoGCAAQBxAeOggIABAIEAcQHjoGCAAQDRAeOgQIIRAKUJrYBlik5AZgq-kGaAFwAngAgAG3AYgBxwiSAQMwLjiYAQCgAQGqAQdnd3Mtd2l6yAEIwAEB&amp;sclient=gws-wiz&amp;ved=0ahUKEwjH39bPrPHvAhVGGFkFHRqBCWUQ4dUDCA0&amp;uact=5">1,114 miles</a>. Also, in the dead of winter.&nbsp;
Hey, I didn&rsquo;t say I was the sharpest tool in the drawer.&nbsp;
Anyway, the point is, Canada&rsquo;s a vast expansive land. At one point in our history, you had to have a brewery in every province where you sold your beer. Today, the big brewers get by with fewer breweries. 
Organigram produces its Edison Bytes <a href="https://medical.organigram.ca/products">chocolate edibles</a> from its plant in Moncton. The first ones went out the door in <a href="https://huddle.today/organigram-begins-shipping-its-first-cannabis-infused-chocolates-this-week/">February 2020</a>.
&ldquo;[Chocolate is] what we&rsquo;ve kind of committed to as our major play within the space,&rdquo; Ray Gracewood, then the SVP of marketing and communications, told Huddle, an online publication focused on Maritimes business. 

&ldquo;We might modify that strategy or look at different product types as we go forward. But for now, our big bet is we think a new sophisticated cannabis consumer is going to really react well to chocolate as a base product.&rdquo;
I&rsquo;ve tried some THC-infused chocolate, but I&rsquo;m more interested in the soft chews area of the cannabis market, so this acquisition really jumped out at me.
<h3>It Needed a Western Base</h3>
Needless to say, the acquisition of EIC gives the company access to a state-of-the-art, 51,000 square foot facility that&rsquo;s capable of producing all kinds of cannabis-infused products, including the all-important soft chews, which represent 75% of the edibles&rsquo; sales in Canada.
Currently, the edibles business has a 4.4% share of the overall Canadian recreational cannabis market. Organigram expects this share to grow to between 12% and 15% over the next few years, just as it has in the U.S. It also expects that soft chews will grow to represent 85% of the edibles market in Canada.
So, I don&rsquo;t think investors should be so dismissive of this purchase. It&rsquo;s a potential game-changer in the Canadian market. I like it a lot.&nbsp;
Something investors probably don&rsquo;t know about the EIC acquisition: AgraFlora Organics International Inc. (OTCMKTS:<a href="https://investorplace.com/stock-quotes/agfaf-stock-quote/">AGFAF</a>) <a href="https://mjbizdaily.com/organigram-acquires-cannabis-edibles-manufacturer-for-ca22-million/?cn-reloaded=1">owned 43%</a> of the business. It started EIC with Cavalier Candies, Western Canada&rsquo;s <a href="http://cavaliercandies.com/">largest sugar confectionery</a> manufacturer.
&ldquo;We value James Fletcher&rsquo;s tremendous knowledge of confectionary manufacturing and proven track record of fulfilling the product needs of some of the world&rsquo;s largest retailers at Cavalier Candies,&rdquo; Organigram&rsquo;s press release stated.
<h3>The Bottom Line on OGI Stock</h3>
I last wrote about OrganiGram in March. At the time, I gave it <a href="https://investorplace.com/2021/02/ogi-stock-organigrams-latest-director-appointment-deserves-closer-scrutiny/">passing grades</a> for the composition of its board of directors. It can do better, but compared to some more established Canadian businesses it&rsquo;s ahead of the curve.&nbsp;
I won&rsquo;t lie, though. OGI is not my favorite cannabis stock.&nbsp;
However, this acquisition makes it an even better buy for speculative investors than in March because it accelerates its plans in an important part of the recreational cannabis market.&nbsp;
From where I sit, if you&rsquo;re a shareholder, I don&rsquo;t know how you don&rsquo;t give this deal an A or B+. It&rsquo;s definitely something to chew on.&nbsp;
On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;
Will Ashworth has written about investments full-time since 2008. Publications where he&rsquo;s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities.
<h3>More From InvestorPlace</h3>
<ul>
<li>
				<a href="https://investorplace.com/2020/05/legendary-stock-pickers-controversial-message-about-5g/?cid=MKT464279&amp;eid=MKT469673"> 
					Why Everyone Is Investing in 5G All WRONG				</a>
			</li>
<li>
				<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT513141"> 
					It doesn&rsquo;t matter if you have $500 in savings or $5 million. Do this now.				</a>
			</li>
<li>
				<a href="https://investorplace.com/2020/02/americas-1-stock-picker-reveals-next-1000-winner-totally-free-of-charge/?cid=MKT462609&amp;eid=MKT465996"> 
					Top Stock Picker Reveals His Next Potential 500% Winner				</a>
			</li>
<li>
				<a href="https://investorplace.com/2021/02/silicon-valley-whiz-kid-reveals-top-tech-stock/?cid=MKT516215&amp;eid=MKT524303"> 
					Stock Prodigy Who Found NIO at $2&hellip; Says Buy THIS Now				</a>
			</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2021/04/ogi-stock-tastey-goes-big-on-edibles/">OrganiGram Looks Pretty Tastey as It Goes Big on Edibles</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OrganiGram Looks Pretty Tastey as It Goes Big on Edibles

AgraFlora inks Farmako supply agreement for THC testkits to STADAPHARM

APHA

TCNNF

VRNOF

Press Releases

AgraFlora Organics Commences High Quality CBD Cultivation at Binbrook Farm

AgraFlora Organics Prepares over 1,000KG of CBD Oil for Sale

REPEAT - AgraFlora Organics Prepares over 1,000KG of CBD Oil for Sale

AgraFlora's Updates on Cultivation at Delta Greenhouse

REPEAT: AgraFlora's Updates on Cultivation at Delta Greenhouse

AgraFlora Organics Commences Research and Development Trials at Winnipeg Based Edibles Manufacturing Facility

AgraFlora's Subsidiary Farmako Secures Additional Supply of EU-GMP Cannabis via Definitive Supply Agreement with ZenPharm Limited

REPEAT – AgraFlora's Subsidiary Farmako Secures Additional Supply of EU-GMP Cannabis via Definitive Supply Agreement with ZenPharm Limited

Health Care

AgraFlora's Subsidiary Farmako Obtains Additional EU-GMP Cannabis for Distribution in Germany

AgraFlora Organics Submits Response to Request for More Information from Health Canada and Moves Towards Processing Licence its Winnipeg Edibles Manufacturing Facility

AgraFlora's Delta Greenhouse Receives Agriculture Loan

AgraFlora Organics Receives Analytical Equipment for its  Winnipeg Edibles Manufacturing Facility

AgraFlora Provides Guidance and Grow Update for its Delta Greenhouse

AgraFlora Organics Receives Standard Processing Licence for its Winnipeg Edibles Manufacturing Facility

AgraFlora Organics Expects to Enter Edibles Market in Q1

AgraFlora Organics Announces anticipated First Sales and Revenue for Summer 2021

Management

Proactive news headlines including HighGold Mining, Codebase Ventures, Victory Square Technologies and Mandalay Resources

AgraFlora Appoints Elise Coppens as New CEO and Director to Implement the Next Phase of its Corporate Strategy

Proactive news headlines including Altamira Gold, AIM ImmunoTech, QC Copper and Gold and Cloud Nine Education

AgraFlora Provides Dial-In Information for Annual General Meeting and Business Update Presentation

AgraFlora Announces AGM Voting Results

AgraFlora Announces Definitive Agreement to Sell its AAA Heidelberg Subsidiary

Proactive news headlines including Milestone Scientific, Nextleaf Solutions, Nano One Materials and Delta 9 Cannabis Inc

AgraFlora and Other Owners Agree to Sell Edibles Business for $35 Million to Organigram

Proactive news headlines including The Parent Company, One World Lithium, Vox Royalty and Global Energy Metals

Proactive news headlines including First Cobalt, Empower Clinics, BetterLife Pharma,  Marble Financial and O3 Mining

AgraFlora Announces Farmako Supply Agreement of Proprietary THC Testkits to STADAPHARM

Recent Quotes

Related Companies

AgraFlora Organics Intl Frequently Asked Questions

How do I buy AgraFlora Organics Intl (AGFAF) stock?

Who are AgraFlora Organics Intl's (AGFAF) competitors?

What is the target price for AgraFlora Organics Intl (AGFAF) stock?

Current Stock Price for AgraFlora Organics Intl (AGFAF)?

Does AgraFlora Organics Intl (AGFAF) pay a dividend?

When is AgraFlora Organics Intl (OTC:AGFAF) reporting earnings?

Is AgraFlora Organics Intl (AGFAF) going to split?

What sector and industry does AgraFlora Organics Intl (AGFAF) operate in?